OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Folate Receptor-Positive Circulating Tumor Cells as a Novel Diagnostic Biomarker in Non-Small Cell Lung Cancer
Yue Yu, Zhaoli Chen, Jingsi Dong, et al.
Translational Oncology (2013) Vol. 6, Iss. 6, pp. 697-702
Open Access | Times Cited: 103

Showing 1-25 of 103 citing articles:

Non‐small cell lung cancer in China
Peixin Chen, Yunhuan Liu, Yaokai Wen, et al.
Cancer Communications (2022) Vol. 42, Iss. 10, pp. 937-970
Open Access | Times Cited: 372

Liquid biopsy for lung cancer early detection
Mariacarmela Santarpía, Alessia Liguori, Alessandro D’Aveni, et al.
Journal of Thoracic Disease (2018) Vol. 10, Iss. S7, pp. S882-S897
Open Access | Times Cited: 114

Lung Cancer Biomarkers
I Hoseok, Je‐Yoel Cho
Advances in clinical chemistry (2015), pp. 107-170
Closed Access | Times Cited: 105

Folate Receptor–Positive Circulating Tumor Cell Detected by LT-PCR–Based Method as a Diagnostic Biomarker for Non–Small-Cell Lung Cancer
Xiaoxia Chen, Fei Zhou, Xuefei Li, et al.
Journal of Thoracic Oncology (2015) Vol. 10, Iss. 8, pp. 1163-1171
Open Access | Times Cited: 103

Liquid biopsy based biomarkers in non-small cell lung cancer for diagnosis and treatment monitoring
David Pérez-Callejo, Atocha Romero, Mariano Provencio, et al.
Translational Lung Cancer Research (2016) Vol. 5, Iss. 5, pp. 455-465
Open Access | Times Cited: 90

Folate Receptor as a Biomarker and Therapeutic Target in Solid Tumors
Olivia Young, Nealie Tan Ngo, Leslie Lin, et al.
Current Problems in Cancer (2022) Vol. 47, Iss. 1, pp. 100917-100917
Open Access | Times Cited: 45

A current review of folate receptor alpha as a potential tumor target in non-small-cell lung cancer
Zhehai Wang, Huan Shi, Jun Guo, et al.
Drug Design Development and Therapy (2015), pp. 4989-4989
Open Access | Times Cited: 88

The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring
Jillian Wilhelmina Paulina Bracht, Clara Mayo‐de‐las‐Casas, Jordi Berenguer, et al.
Current Oncology Reports (2018) Vol. 20, Iss. 9
Closed Access | Times Cited: 72

Current and future applications of liquid biopsy in non-small-cell lung cancer—a narrative review
Bartłomiej Tomasik, Marcin Skrzypski, Michał Bieńkowski, et al.
Translational Lung Cancer Research (2023) Vol. 12, Iss. 3, pp. 594-614
Open Access | Times Cited: 19

Current Status of CTCs as Liquid Biopsy in Lung Cancer and Future Directions
Zhuo Zhang, Nithya Ramnath, Sunitha Nagrath
Frontiers in Oncology (2015) Vol. 5
Open Access | Times Cited: 59

Clinical utility of circulating tumor cells in patients with non-small-cell lung cancer
Marianna Gallo, Antonella De Luca, Monica R. Maiello, et al.
Translational Lung Cancer Research (2017) Vol. 6, Iss. 4, pp. 486-498
Open Access | Times Cited: 49

Liquid biopsy for early diagnosis of non-small cell lung carcinoma: recent research and detection technologies
Chang Lu, Jinming Li, Rui Zhang
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 3, pp. 188729-188729
Closed Access | Times Cited: 27

Liquid Biopsy in NSCLC: An Investigation with Multiple Clinical Implications
Elisa Bertoli, Elisa De Carlo, Debora Basile, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10803-10803
Open Access | Times Cited: 14

Synergistic Therapy of Doxorubicin and miR-129-5p with Self-Cross-Linked Bioreducible Polypeptide Nanoparticles Reverses Multidrug Resistance in Cancer Cells
Huqiang Yi, Lanlan Liu, Nan Sheng, et al.
Biomacromolecules (2016) Vol. 17, Iss. 5, pp. 1737-1747
Closed Access | Times Cited: 41

Combined use of EpCAM and FRα enables the high-efficiency capture of circulating tumor cells in non-small cell lung cancer
Luojun Chen, Min Peng, Na Li, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 40

Evaluation of Cell Surface Vimentin Positive Circulating Tumor Cells as a Diagnostic Biomarker for Lung Cancer
Xiaohong Xie, Liqiang Wang, Xinni Wang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 30

An IgE antibody targeting HER2 identified by clonal selection restricts breast cancer growth via immune-stimulating activities
Lais C. G. F. Palhares, Melanie Grandits, Katie Stoker, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access

Isolation of Circulating Tumor Cells from Multiple Epithelial Cancers with ApoStream® for Detecting (or Monitoring) the Expression of Folate Receptor Alpha
Daniel J. O’Shannessy, Darren W. Davis, Kenna Anderes, et al.
Biomarker Insights (2016) Vol. 11, pp. BMI.S35075-BMI.S35075
Open Access | Times Cited: 34

The combination of CTCs and CEA can help guide the management of patients with SPNs suspected of being lung cancer
Jian Zheng, Ye Xiong, Yanan Liu, et al.
BMC Cancer (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 30

Circulating tumor cells in early stage lung adenocarcinoma: a case series report and literature review
Xu-Rui Jin, Lu-Yao Zhu, Kai Qian, et al.
Oncotarget (2017) Vol. 8, Iss. 14, pp. 23130-23141
Open Access | Times Cited: 28

Page 1 - Next Page

Scroll to top